NKTR logo

Nektar Therapeutics (NKTR) Net Income

Annual Net Income:

-$118.96M+$157.09M(+56.91%)
December 31, 2024

Summary

  • As of today, NKTR annual net profit is -$118.96 million, with the most recent change of +$157.09 million (+56.91%) on December 31, 2024.
  • During the last 3 years, NKTR annual net income has risen by +$404.88 million (+77.29%).
  • NKTR annual net income is now -117.46% below its all-time high of $681.31 million, reached on December 31, 2018.

Performance

NKTR Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Quarterly Net Income:

-$41.59M+$9.29M(+18.26%)
June 30, 2025

Summary

  • As of today, NKTR quarterly net profit is -$41.59 million, with the most recent change of +$9.29 million (+18.26%) on June 30, 2025.
  • Over the past year, NKTR quarterly net income has increased by +$10.77 million (+20.57%).
  • NKTR quarterly net income is now -104.28% below its all-time high of $971.46 million, reached on June 30, 2018.

Performance

NKTR Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM Net Income:

-$122.27M+$10.77M(+8.10%)
June 30, 2025

Summary

  • As of today, NKTR TTM net profit is -$122.27 million, with the most recent change of +$10.77 million (+8.10%) on June 30, 2025.
  • Over the past year, NKTR TTM net income has increased by +$54.81 million (+30.95%).
  • NKTR TTM net income is now -113.54% below its all-time high of $902.71 million, reached on June 30, 2018.

Performance

NKTR TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

NKTR Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+56.9%+20.6%+30.9%
3Y3 Years+77.3%+73.8%+76.7%
5Y5 Years+73.0%+48.0%+72.2%

NKTR Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+77.3%-672.8%+69.6%-2.8%+73.1%
5Y5-Yearat high+77.3%-672.8%+73.8%-2.8%+76.7%
All-TimeAll-Time-117.5%+77.3%-104.3%+73.8%-113.5%+76.7%

NKTR Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.59M(+18.3%)
-$122.27M(+8.1%)
Mar 2025
-
-$50.88M(-800.8%)
-$133.04M(-11.8%)
Dec 2024
-$118.96M(+56.9%)
$7.26M(+119.6%)
-$118.96M(+29.3%)
Sep 2024
-
-$37.06M(+29.2%)
-$168.30M(+5.0%)
Jun 2024
-
-$52.36M(-42.3%)
-$177.08M(-0.7%)
Mar 2024
-
-$36.80M(+12.5%)
-$175.84M(+36.3%)
Dec 2023
-$276.06M(+25.0%)
-$42.08M(+8.2%)
-$276.06M(+6.0%)
Sep 2023
-
-$45.84M(+10.3%)
-$293.67M(+4.3%)
Jun 2023
-
-$51.12M(+62.7%)
-$306.88M(+26.0%)
Mar 2023
-
-$137.02M(-129.6%)
-$414.82M(-12.7%)
Dec 2022
-$368.20M(+29.7%)
-$59.69M(-1.1%)
-$368.20M(+18.9%)
Sep 2022
-
-$59.05M(+62.9%)
-$454.15M(+13.5%)
Jun 2022
-
-$159.07M(-76.0%)
-$524.81M(-6.8%)
Mar 2022
-
-$90.39M(+37.9%)
-$491.26M(+6.2%)
Dec 2021
-$523.84M(-17.9%)
-$145.65M(-12.3%)
-$523.84M(-5.7%)
Sep 2021
-
-$129.71M(-3.3%)
-$495.39M(-4.5%)
Jun 2021
-
-$125.52M(-2.1%)
-$474.27M(-10.6%)
Mar 2021
-
-$122.97M(-4.9%)
-$428.76M(+3.5%)
Dec 2020
-$444.44M(-0.9%)
-$117.20M(-7.9%)
-$444.44M(-1.1%)
Sep 2020
-
-$108.59M(-35.7%)
-$439.40M(-2.3%)
Jun 2020
-
-$80.00M(+42.3%)
-$429.40M(+6.6%)
Mar 2020
-
-$138.65M(-23.6%)
-$459.69M(-4.3%)
Dec 2019
-$440.67M(-164.7%)
-$112.16M(-13.8%)
-$440.67M(-3.3%)
Sep 2019
-
-$98.58M(+10.6%)
-$426.71M(-0.6%)
Jun 2019
-
-$110.29M(+7.8%)
-$424.27M(-164.5%)
Mar 2019
-
-$119.63M(-21.8%)
$657.47M(-3.5%)
Dec 2018
$681.31M(+804.6%)
-$98.21M(-2.2%)
$681.31M(-8.6%)
Sep 2018
-
-$96.14M(-109.9%)
$745.70M(-17.4%)
Jun 2018
-
$971.46M(+1114.1%)
$902.71M(+801.9%)
Mar 2018
-
-$95.79M(-183.2%)
-$128.62M(-33.0%)
Dec 2017
-$96.69M(+37.0%)
-$33.83M(-155.6%)
-$96.69M(+8.0%)
Sep 2017
-
$60.87M(+201.7%)
-$105.06M(+49.8%)
Jun 2017
-
-$59.87M(+6.3%)
-$209.16M(-5.7%)
Mar 2017
-
-$63.87M(-51.3%)
-$197.89M(-28.9%)
Dec 2016
-$153.52M(-89.1%)
-$42.20M(+2.4%)
-$153.52M(+7.2%)
Sep 2016
-
-$43.22M(+11.1%)
-$165.46M(-26.8%)
Jun 2016
-
-$48.60M(-149.3%)
-$130.44M(+3.0%)
Mar 2016
-
-$19.50M(+64.0%)
-$134.50M(-65.7%)
Dec 2015
-$81.18M(-50.6%)
-$54.14M(-560.0%)
-$81.18M(-11.6%)
Sep 2015
-
-$8.20M(+84.4%)
-$72.72M(-1295.1%)
Jun 2015
-
-$52.66M(-255.7%)
$6.08M(-76.7%)
Mar 2015
-
$33.82M(+174.0%)
$26.11M(+148.4%)
Dec 2014
-$53.92M(+66.7%)
-$45.68M(-164.7%)
-$53.92M(+3.5%)
Sep 2014
-
$70.61M(+316.3%)
-$55.89M(+60.9%)
Jun 2014
-
-$32.64M(+29.4%)
-$143.04M(+6.6%)
Mar 2014
-
-$46.20M(+3.1%)
-$153.15M(+5.5%)
Dec 2013
-$162.01M(+5.7%)
-$47.66M(-188.1%)
-$162.01M(+3.1%)
Sep 2013
-
-$16.54M(+61.3%)
-$167.28M(+13.9%)
Jun 2013
-
-$42.75M(+22.4%)
-$194.28M(-4.6%)
Mar 2013
-
-$55.06M(-4.0%)
-$185.82M(-8.1%)
Dec 2012
-$171.85M(-28.3%)
-$52.93M(-21.5%)
-$171.85M(-9.9%)
Sep 2012
-
-$43.55M(-27.0%)
-$156.42M(-14.2%)
Jun 2012
-
-$34.28M(+16.6%)
-$136.94M(+1.5%)
Mar 2012
-
-$41.10M(-9.6%)
-$139.04M(-3.8%)
Dec 2011
-$133.98M(-253.1%)
-$37.49M(-55.8%)
-$133.98M(-12.5%)
Sep 2011
-
-$24.07M(+33.8%)
-$119.06M(-14.8%)
Jun 2011
-
-$36.38M(-1.0%)
-$103.71M(-52.9%)
Mar 2011
-
-$36.03M(-59.6%)
-$67.84M(-78.8%)
Dec 2010
-$37.94M(+63.0%)
-$22.58M(-159.2%)
-$37.94M(-64.7%)
Sep 2010
-
-$8.71M(-1584.9%)
-$23.03M(+49.1%)
Jun 2010
-
-$517.00K(+91.6%)
-$45.29M(+41.1%)
Mar 2010
-
-$6.13M(+20.1%)
-$76.84M(+25.0%)
Dec 2009
-$102.52M
-$7.68M(+75.2%)
-$102.52M(-467.6%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$30.97M(+3.4%)
-$18.06M(+25.2%)
Jun 2009
-
-$32.07M(-0.8%)
-$24.13M(+5.1%)
Mar 2009
-
-$31.81M(-141.4%)
-$25.44M(+25.9%)
Dec 2008
-$34.34M(-4.8%)
$76.78M(+307.3%)
-$34.34M(+52.4%)
Sep 2008
-
-$37.04M(-11.0%)
-$72.08M(-34.3%)
Jun 2008
-
-$33.38M(+18.0%)
-$53.66M(-12.3%)
Mar 2008
-
-$40.70M(-204.3%)
-$47.79M(-45.9%)
Dec 2007
-$32.76M(+78.8%)
$39.04M(+309.7%)
-$32.76M(+70.4%)
Sep 2007
-
-$18.62M(+32.3%)
-$110.66M(+0.9%)
Jun 2007
-
-$27.51M(-7.2%)
-$111.64M(+24.0%)
Mar 2007
-
-$25.67M(+33.9%)
-$146.96M(+5.0%)
Dec 2006
-$154.76M(+16.4%)
-$38.85M(-98.2%)
-$154.76M(+31.0%)
Sep 2006
-
-$19.60M(+68.8%)
-$224.15M(+1.8%)
Jun 2006
-
-$62.83M(-87.7%)
-$228.34M(-18.7%)
Mar 2006
-
-$33.47M(+69.1%)
-$192.42M(-3.9%)
Dec 2005
-$185.11M(-81.7%)
-$108.24M(-354.9%)
-$185.11M(-92.5%)
Sep 2005
-
-$23.80M(+11.6%)
-$96.14M(-3.6%)
Jun 2005
-
-$26.91M(-2.9%)
-$92.80M(-5.4%)
Mar 2005
-
-$26.16M(-35.8%)
-$88.05M(+13.6%)
Dec 2004
-$101.89M(-118.3%)
-$19.27M(+5.8%)
-$101.89M(-28.8%)
Sep 2004
-
-$20.45M(+7.7%)
-$79.10M(-4.3%)
Jun 2004
-
-$22.16M(+44.6%)
-$75.86M(-13.7%)
Mar 2004
-
-$40.00M(-1239.0%)
-$66.73M(-43.0%)
Dec 2003
-$46.68M(+56.6%)
$3.51M(+120.4%)
-$46.68M(+42.6%)
Sep 2003
-
-$17.21M(-32.0%)
-$81.27M(+10.3%)
Jun 2003
-
-$13.04M(+34.6%)
-$90.58M(+11.5%)
Mar 2003
-
-$19.95M(+35.8%)
-$102.36M(+4.8%)
Dec 2002
-$107.47M(+57.0%)
-$31.07M(-17.2%)
-$107.47M(+4.6%)
Sep 2002
-
-$26.52M(-6.9%)
-$112.65M(+0.4%)
Jun 2002
-
-$24.82M(+1.0%)
-$113.05M(+41.7%)
Mar 2002
-
-$25.06M(+30.9%)
-$194.02M(+22.4%)
Dec 2001
-$250.01M(-156.7%)
-$36.25M(-34.7%)
-$250.01M(+1.3%)
Sep 2001
-
-$26.92M(+74.6%)
-$253.37M(-5.7%)
Jun 2001
-
-$105.79M(-30.5%)
-$239.66M(-60.2%)
Mar 2001
-
-$81.04M(-104.6%)
-$149.61M(-53.6%)
Dec 2000
-$97.40M(-153.3%)
-$39.61M(-199.7%)
-$97.40M(-24.9%)
Sep 2000
-
-$13.21M(+16.1%)
-$77.97M(-8.6%)
Jun 2000
-
-$15.75M(+45.4%)
-$71.80M(-15.7%)
Mar 2000
-
-$28.83M(-42.9%)
-$62.06M(-61.4%)
Dec 1999
-$38.45M(-109.5%)
-$20.17M(-186.4%)
-$38.45M(-56.4%)
Sep 1999
-
-$7.04M(-17.3%)
-$24.59M(-8.9%)
Jun 1999
-
-$6.01M(-15.0%)
-$22.59M(-16.2%)
Mar 1999
-
-$5.22M(+17.3%)
-$19.43M(-5.9%)
Dec 1998
-$18.36M(-83.9%)
-$6.32M(-25.2%)
-$18.36M(-22.1%)
Sep 1998
-
-$5.04M(-76.9%)
-$15.03M(-18.9%)
Jun 1998
-
-$2.85M(+31.3%)
-$12.64M(-4.6%)
Mar 1998
-
-$4.15M(-38.8%)
-$12.09M(-21.1%)
Dec 1997
-$9.98M(-0.7%)
-$2.99M(-12.8%)
-$9.98M(+3.9%)
Sep 1997
-
-$2.65M(-15.4%)
-$10.39M(-3.5%)
Jun 1997
-
-$2.30M(-12.4%)
-$10.04M(+2.0%)
Mar 1997
-
-$2.04M(+39.9%)
-$10.24M(-1.4%)
Dec 1996
-$9.91M(-29.3%)
-$3.40M(-47.8%)
-$10.10M(-12.2%)
Sep 1996
-
-$2.30M(+8.0%)
-$9.00M(-7.1%)
Jun 1996
-
-$2.50M(-31.6%)
-$8.40M(-12.0%)
Mar 1996
-
-$1.90M(+17.4%)
-$7.50M(+3.8%)
Dec 1995
-$7.66M(-45.1%)
-$2.30M(-35.3%)
-$7.80M(0.0%)
Sep 1995
-
-$1.70M(-6.3%)
-$7.80M(-11.4%)
Jun 1995
-
-$1.60M(+27.3%)
-$7.00M(-11.1%)
Mar 1995
-
-$2.20M(+4.3%)
-$6.30M(-21.2%)
Dec 1994
-$5.28M
-$2.30M(-155.6%)
-$5.20M(-79.3%)
Sep 1994
-
-$900.00K(0.0%)
-$2.90M(-45.0%)
Jun 1994
-
-$900.00K(+18.2%)
-$2.00M(-81.8%)
Mar 1994
-
-$1.10M
-$1.10M

FAQ

  • What is Nektar Therapeutics annual net profit?
  • What is the all-time high annual net income for Nektar Therapeutics?
  • What is Nektar Therapeutics annual net income year-on-year change?
  • What is Nektar Therapeutics quarterly net profit?
  • What is the all-time high quarterly net income for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly net income year-on-year change?
  • What is Nektar Therapeutics TTM net profit?
  • What is the all-time high TTM net income for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM net income year-on-year change?

What is Nektar Therapeutics annual net profit?

The current annual net income of NKTR is -$118.96M

What is the all-time high annual net income for Nektar Therapeutics?

Nektar Therapeutics all-time high annual net profit is $681.31M

What is Nektar Therapeutics annual net income year-on-year change?

Over the past year, NKTR annual net profit has changed by +$157.09M (+56.91%)

What is Nektar Therapeutics quarterly net profit?

The current quarterly net income of NKTR is -$41.59M

What is the all-time high quarterly net income for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly net profit is $971.46M

What is Nektar Therapeutics quarterly net income year-on-year change?

Over the past year, NKTR quarterly net profit has changed by +$10.77M (+20.57%)

What is Nektar Therapeutics TTM net profit?

The current TTM net income of NKTR is -$122.27M

What is the all-time high TTM net income for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM net profit is $902.71M

What is Nektar Therapeutics TTM net income year-on-year change?

Over the past year, NKTR TTM net profit has changed by +$54.81M (+30.95%)
On this page